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24 The Journal of Thoracic and Cardion this issue of the Journal, Melby and colleagues1 present a preclinical study 
microwave radiation used to ablate the atrium of the beating heart. It is the first
article to address the important issue of ablation effectiveness when energies are
pplied to the epicardium of the beating, working heart with a device that lends itself
o a minimal-access approach. It is an important initial contribution to our nascent
nowledge base, and it is a well-performed study.
There are 2 very important overarching questions raised by this type of research.
he first really concerns the future of atrial fibrillation surgery: Can ablative energy
ources create truly transmural lesions when used from the epicardium on the
eating, filled heart? Fortunately, this is a purely technical question; with the right
nimal (and perhaps human) models it can be definitively answered. The second
uestion, however, is much more vexing: Are transmural lesions necessary to cure
trial fibrillation? We certainly have an extensive and detailed database gathered
ver the last 15 years concerning the Maze operation, a procedure that ensured
ransmurality by virtue of its cut-and-sew lesions; we know the results with that
pproach. As the field of atrial fibrillation surgery moves to less-destructive and
ess-invasive methods in a drive to treat more patients, it may no longer be possible
o use this experience as a guide.
Let us first consider the question of transmural lesion creation. There is a
ewildering array of ablative energy sources available to the surgeon in 2006: Dry
nipolar radiofrequency (RF), dry bipolar RF, irrigated unipolar RF, irrigated
ipolar RF, microwave, laser, ultrasound, and cryothermy. There are even investi-
ations into the use of  radiation. All of these devices have been used in the
pen-chest setting and many are even available in a percutaneous delivery vehicle.
When applied from the endocardium on an arrested, cooled heart, nearly all of the
nergy sources appear able to create deep, transmural, and fairly well-controlled
esions. However, when applied from the epicardium while the heart is beating and
lled with blood, the situation is quite different. Unipolar RF does not appear to
reate transmural lesions too well: Only 22% of lesions were transmural acutely in
 human study,2 and only 33% were transmural acutely in a sheep model.2 Bipolar
F was more effective, achieving transmurality between 92% and 100% of the time
n a variety of experimental situations, acutely or chronically, on or off cardiopul-
onary bypass.3-7
It is likely that the single most significant difference here is whether the device
an stop blood flow near the ablating element, eliminating the thermal sink effect
nd greatly increasing the depth of lesion penetration. This hypothesis is supported
y investigations on the effects of cryothermy, in which ablation from the epicar-
ium on beating hearts of dogs demonstrated that 93% of clamped were transmural,
et only 84% of linear, unclamped lesions completely crossed the atrial 8
nfortunately, this increase in efficacy comes at the expense of much more limited
evice flexibility.
Microwave radiation, a unipolar ablation method, has shown inconsistent results
ith transmurality achieved from the epicardium in 48% to 100% of applica-
ions.9-11 In our laboratory we too have been studying microwave radiation and
ound that 89% of acute epicardial beating-heart lesions are transmural; how many
ore “become” transmural after 3 months of recovery is still under investigation
nd should help determine whether scar formation and healing are important factors
n producing transmural lesions over the long term.
vascular Surgery ● August 2006
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LIn 2006, therefore, the surgeon is faced with this di-
emma: Bipolar clamp devices are more effective at creating
ransmural lesions yet are larger and less “minimally inva-
ive,” whereas unipolar devices are more flexible, generally
f lower profile, and “easier” to use with minimal access
echniques yet do not so predictably create transmural le-
ions (there is too much reliance on energy dosimetry). In
he best of all worlds the surgeon would use a device that is
mall, flexible, adaptable to any lesion pattern, and yet gives
ome kind of real-time feedback ensuring that a transmural
esion has been made.
Yet is this really necessary? Is a transmural lesion re-
uired to effectively “cure” atrial fibrillation? Indeed, why
o many clinical studies document an 80% or higher cure
ate when the preclinical data do not show nearly so high a
ransmurality rate? This is the second question posed ear-
ier: Is transmurality necessary? There is evidence accumu-
ating from the catheter-based approach that it is likely not
equired and in fact is often not achieved during ablation
hen electrical isolation is used as the treatment end
oint.12-14 So, if we are not aiming for transmurality, 
hat is our goal?
Perhaps tissue temperature is a better measure of the
dequacy and predictability of lesion formation. In a study
f isolated guinea pig hearts, perfusion with fluid tempera-
ure greater than 55°C resulted in irreversible cessation of
lectrical conduction, whereas perfusion with fluid temper-
ture of 45°C to 55°C only temporarily arrested conduc-
ion.15 In our laboratory we have found that epicar
icrowave energy increases right ventricular endocardial
ree wall tissue temperature to more than 55°C after 80
econds at 65 watts. We have not studied the atrium, where
he heat sink effect of flowing blood may be more pro-
ounced. Furthermore, we fully appreciate the technical
hallenge associated with performing such measurements in
linical application.
So what are the answers to the questions facing us in
006? As we strive to perfect a procedure that can effec-
ively treat atrial fibrillation while being minimally inva-
ive, we do not yet have the perfect tool. Much work still
eeds to be done to develop a device or devices that can
eliably create transmural lesions in atrial muscle while the
eart is full and beating. We also must determine what end
oints should be measured during ablation so the operating
urgeon can be sure that he or she is creating an adequate
njury. Whether that injury actually needs to be transmural
r to a certain temperature or perhaps to some other mea-
The Journal of Thoracicurement also remains to be determined. Melby and col-
eagues1 are to be congratulated for taking the first b
tep into this wilderness. Their contribution is a valuable
ne and sets the mark for future studies in this exciting,
eveloping field.
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